Human γδ T-Cell Control of Mucosal Immunity and Inflammation.
Human γδ T-Cell Control of Mucosal Immunity and Inflammation.
复制标题
DOI:
10.3389/fimmu.2018.00985
复制
发表时间:
2018
影响因子:
7.3
通讯作者:
Eberl M
中科院分区:
文献类型:
--
作者:
McCarthy NE;Eberl M
Human γδ T-cells include some of the most common “antigen-specific” cell types in peripheral blood and are enriched yet further at mucosal barrier sites where microbial infection and tumors often originate. While the γδ T-cell compartment includes multiple subsets with highly flexible effector functions, human mucosal tissues are dominated by host stress-responsive Vδ1+ T-cells and microbe-responsive Vδ2+ T-cells. Widely recognized for their potent cytotoxicity, emerging data suggest that γδ T-cells also exert strong influences on downstream adaptive immunity to pathogens and tumors, in particular via activation of antigen-presenting cells and/or direct stimulation of other mucosal leukocytes. These unique functional attributes and lack of MHC restriction have prompted considerable interest in therapeutic targeting of γδ T-cells. Indeed, several drugs already in clinical use, including vedolizumab, infliximab, and azathioprine, likely owe their efficacy in part to modulation of γδ T-cell function. Recent clinical trials of Vδ2+ T-cell-selective treatments indicate a good safety profile in human patients, and efficacy is set to increase as more potent/targeted drugs continue to be developed. Key advances will include identifying methods of directing γδ T-cell recruitment to specific tissues to enhance host protection against invading pathogens, or alternatively, retaining these cells in the circulation to limit peripheral inflammation and/or improve responses to blood malignancies. Human γδ T-cell control of mucosal immunity is likely exerted via multiple mechanisms that induce diverse responses in other types of tissue-resident leukocytes. Understanding the microenvironmental signals that regulate these functions will be critical to the development of new γδ T-cell-based therapies.
登录
查看更多内容
DOI:
10.1084/jem.172.1.239
发表时间:
1990-07-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Bandeira A;Mota-Santos T;Itohara S;Degermann S;Heusser C;Tonegawa S;Coutinho A
通讯作者:
Coutinho A
DOI:
10.4049/jimmunol.1601060
发表时间:
2017-01-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Do JS;Kim S;Keslar K;Jang E;Huang E;Fairchild RL;Pizarro TT;Min B
通讯作者:
Min B
影响因子:
2.4
作者:
Dart RJ;Samaan MA;Powell N;Irving PM
通讯作者:
Irving PM
影响因子:
4.4
作者:
Ali, Zahida;Shao, Lingyan;Chen, Zheng W.
通讯作者:
Chen, Zheng W.
影响因子:
56.9
作者:
Bauer, S;Groh, V;Spies, T
通讯作者:
Spies, T